ONYX PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
ONYX PHARMACEUTICALS INC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $52.20 million as of 2011-12-31, per its 10-K filed 2012-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2012-02-27
- 2011-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $52.20M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2011-12-31 | $52.20M 10-K · filed 2012-02-27 |